13F-HR filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 35 holding rows worth $2,613,016,030.
- Accession
- 0001855655-24-000009
- Filer
- CIK 1855655
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 35 entries on the cover page, a total value of $2,613,016,030 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,613,016,030 with VALUE read as dollars as filed, 13F file number 028-21950. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 4,571,678 | $346,807,493 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 538,139 | $231,421,296 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 3,848,095 | $212,376,363 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 5,259,089 | $204,105,244 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 947,574 | $149,716,692 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 2,704,718 | $121,901,640 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 2,019,814 | $119,512,394 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 2,513,302 | $112,570,797 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 2,330,508 | $95,294,472 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 4,539,381 | $93,465,855 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 664,307 | $90,598,189 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 7,903,600 | $85,516,952 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,043,280 | $79,667,487 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,435,416 | $66,194,607 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 1,564,452 | $65,534,894 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 2,438,149 | $64,903,526 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,203,308 | $53,294,511 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 627,202 | $47,360,023 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 3,870,594 | $46,756,776 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,325,449 | $41,881,336 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 3,421,965 | $39,763,233 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,896,349 | $37,681,500 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,362,827 | $35,978,633 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,624,342 | $30,553,203 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,089,492 | $27,596,832 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,542,805 | $26,906,519 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 7,250,000 | $17,110,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 2,335,926 | $14,108,993 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 330,000 | $12,985,500 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 721,087 | $10,426,918 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,575,605 | $9,500,898 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 919,692 | $9,169,329 | dollars as filed | |
| VOR BIOPHARMA INC | 929033108 | COM | 6,457,293 | $6,457,293 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 659,724 | $3,826,399 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 353,886 | $2,070,233 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001855655-24-000009 | this filing | 2024-08-14 | acceptance time not in the bulk data set |